ADVERTISEMENT
💊 What Was Recalled?
The medication involved is prazosin hydrochloride, a drug widely used to treat high blood pressure and sometimes prescribed for other health concerns such as sleep problems related to PTSD. (ABC7 New York)
⚠️ Why the Recall Happened
The Food and Drug Administration (FDA) classified the recall as a Class II recall, meaning the medication may cause temporary or medically reversible adverse health effects if taken, although serious harm is considered unlikely for most people. (MedPath)
Officials say the issue stems from the presence of nitrosamine impurities, specifically N-nitroso Prazosin impurity C, which belongs to a class of chemicals that are considered potentially cancer-causing when exposure levels exceed acceptable limits over a long period. (MedPath)
Nitrosamines are known contaminants in some medicines when manufacturing or storage conditions are not tightly controlled—a concern the FDA has flagged in previous drug recalls as well. (Harvard Health)
📦 How Many Bottles and Dosages Are Affected?
The recall includes prazosin hydrochloride in the following dosage strengths:
- 1 mg capsules – over 181,000 bottles
- 2 mg capsules – nearly 292,000 bottles
- 5 mg capsules – about 108,000 bottles (MedPath)
These bottles were distributed across the U.S. through pharmacies and wholesalers, and the issue affects a broad portion of the medication supply. (MedPath)
🩺 What Patients Should Do
If you are currently taking this medication:
✅ Don’t stop your medication abruptly.
Stopping blood pressure medicine without medical guidance can be dangerous. (Harvard Health)
📞 Contact your doctor or pharmacist right away if you think you have medication from the recalled lots. They can help you verify the lot number and discuss safe alternatives.
🧾 Check the bottle’s label and lot number, and compare it with the recall information provided by your pharmacy or healthcare provider.
🧠 Understanding the Risk
This is not the first time blood pressure medications have been pulled from the market due to manufacturing impurities—similar issues have arisen with other drugs when active pharmaceutical ingredients (APIs) came from unapproved sources or testing controls failed. (fiercepharma.com)
ADVERTISEMENT